These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 9018460

  • 1. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM.
    Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis of Raynaud's phenomenon.
    Herrick AL.
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [Abstract] [Full Text] [Related]

  • 3. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P.
    Rev Prat; 1998 Oct 01; 48(15):1659-64. PubMed ID: 9814067
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M, Cobankara V, Akpolat T.
    Ann Pharmacother; 2007 Sep 01; 41(9):1544-7. PubMed ID: 17666574
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis.
    Sunderkötter C, Riemekasten G.
    Rheumatology (Oxford); 2006 Oct 01; 45 Suppl 3():iii33-5. PubMed ID: 16987831
    [Abstract] [Full Text] [Related]

  • 8. Raynaud's phenomenon and systemic sclerosis.
    Generini S, Kahaleh B, Matucci-Cerinic M, Pignone A, Lombardi A, Ohtsuka T.
    Ann Ital Med Int; 1996 Oct 01; 11(2):125-31. PubMed ID: 8974438
    [Abstract] [Full Text] [Related]

  • 9. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR, Harris JN.
    J Rheumatol; 1985 Feb 01; 12(1):99-103. PubMed ID: 2580093
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon.
    Pancera P, Sansone S, Presciuttini B, Montagna L, Cerù S, Lunardi C, Lechi A.
    Clin Sci (Lond); 1999 Jan 01; 96(1):49-57. PubMed ID: 9857106
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R, Shariat K, von Wilmowsky H, Böhm M.
    Circulation; 2005 Nov 08; 112(19):2980-5. PubMed ID: 16275885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.